Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials

BACKGROUND AND AIMS: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis. Here, we evaluate the efficacy and safety of tofacitinib re-treatment following treatment interruption in patients with ulcerative colitis. METHODS: Here, patients with clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Panés, Julian, Vermeire, Séverine, Dubinsky, Marla C, Loftus, Edward V, Lawendy, Nervin, Wang, Wenjin, Salese, Leonardo, Su, Chinyu, Modesto, Irene, Guo, Xiang, Colombel, Jean-Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575053/
https://www.ncbi.nlm.nih.gov/pubmed/33884415
http://dx.doi.org/10.1093/ecco-jcc/jjab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575053/
https://www.ncbi.nlm.nih.gov/pubmed/33884415
http://dx.doi.org/10.1093/ecco-jcc/jjab065

Ejemplares similares